RO7763505

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7763505, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease [Phase 1]

See pricing